Mark Sarlo is a Senior Scientist specializing in Clinical Safety and Risk Management in Oncology at Merck since 2022. They previously served as a Pharmacist in Drug Product Development at The Janssen Pharmaceutical Companies of Johnson & Johnson from 2020 to 2022 and completed a PGY1 Pharmacy Residency at New York-Presbyterian Hospital in 2020. Mark holds an M.B.A. from West Virginia University and is currently pursuing a Doctor of Pharmacy, a Master of Science in Pharmacology, and a Bachelor of Arts in Biological Sciences, all from various institutions.
This person is not in the org chart
This person is not in any teams
This person is not in any offices